Valerie Barnett is CHIEF LEGAL OFFICER of Cytek Biosciences, Inc.. Currently has a direct ownership of 73,372 shares of CTKB, which is worth approximately $267,807. The most recent transaction as insider was on Aug 18, 2022, when has been sold 2,016 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 73.4K
16.74% 3M change
102.86% 12M change
Total Value Held $267,807

Valerie Barnett Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 18 2022
BUY
Exercise of conversion of derivative security
-
2,016 Added 9.75%
18,667 Common Stock
May 18 2022
SELL
Payment of exercise price or tax liability
$10,104 $9.65 p/Share
1,047 Reduced 6.94%
14,041 Common Stock
May 18 2022
BUY
Exercise of conversion of derivative security
-
2,688 Added 15.12%
15,088 Common Stock
Mar 04 2022
BUY
Exercise of conversion of derivative security
$49,455 $4.71 p/Share
10,500 Added 45.85%
12,400 Common Stock
Jul 22 2021
BUY
Open market or private purchase
$32,300 $17.0 p/Share
1,900 Added 50.0%
1,900 Common Stock
VB

Valerie Barnett

CHIEF LEGAL OFFICER
Fremont, CA

Track Institutional and Insider Activities on CTKB

Follow Cytek Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

News

Receive news related to Cytek Biosciences, Inc.

Track Activities on CTKB